Our patented Sound Bites platform offers a convenient, unbiased way for oncologists to stay up-to-date.

Critical, on-demand information right at your fingertips when and where it is most convenient for you. Subscribe to receive 60 – 90 second video clips from thought leaders via text message.

Credible oncology updates at your fingertips.

Free. No ads. No bias.

Enter our monthly iPad Giveaway!
Earn an entry each time you watch a full Sound Bites video. It's that easy.

Browse Clinical Trial Updates

All

Breast Cancer

CNS Malignancies

Conference Updates

Diagnostics

GI Cancers

GU Cancers

GYN Oncology

Hematologic Malignancies

Lung Cancer

Skin Cancer

What sets iberdomide apart from established IMiDs? Dr. Rahul Banerjee explains. (Video 1/3)

What Sets Iberdomide Apart from Established IMiDs

Rahul Banerjee, MD

Hematologic Malignancies

Dr. Gabriela Hobbs examines how ropeginterferon moves beyond disease control toward disease modification in the treatment of polycythemia vera. (Video 2/3)

Disease modification with ropeginterferon - altering the course of disease

Gabriela Hobbs, MD

Hematologic Malignancies

Dr. Eytan Stein reviews the patient impact of treating AML at the first opportunity versus waiting for mutational testing (Video 2/3)

AML patient impact

Eytan Stein, MD

Hematologic Malignancies

Dr. Wade Iams discusses adverse event prophylaxis strategies for patients with EGFRm mNSCLC on 1L amivantamab subQ + lazertinib (Video 1/3)

COPERNICUS Design, Efficacy

Wade Iams, MD

Lung Cancer

What makes ropeginterferon a modern interferon? Dr. Gabriela Hobbs explains. (Video 1/3)

Differentiating ropeginterferon as the “modern” interferon

Gabriela Hobbs, MD

Hematologic Malignancies

Dr. Eytan Stein discusses durability of treatment in IC-ineligible AML (Video 1/3)

AML durability of treatment

Eytan Stein, MD

Hematologic Malignancies

Why subscribe?

Get one-minute, non-promotional, educational videos from distinguished thought leaders
Tailored to topics you select
- Breast Cancer
- Lung Cancer
- Gastrointestinal Cancers
- Genitourinary Cancers
- Gynecologic Cancers
- Hemotologic Malignancies
- Conference updates and more
No spam. No ads. No apps to download.
Always free and you can opt-out anytime if you feel this isn’t for you.

Fill out the form above to subscribe!

Our patented Sound Bites platform offers a convenient, unbiased way for oncologists to stay up-to-date.

Critical, on-demand information right at your fingertips when and where it is most convenient for you. Subscribe to receive 60 – 90 second video clips from thought leaders via text message.

Intended for USA healthcare providers only.

IDEOlogy Health Ranks No. 772 on the 2025 Inc. 5000 Fastest-Growing Private Companies in America